March 23, 2018 / 6:42 AM / a month ago

BRIEF-Mithra Pharmaceuticals Announces Completion Of Estelle Cycles In Phase III Contraception Studies

March 23 (Reuters) - MITHRA PHARMACEUTICALS SA:

* MITHRA ANNOUNCES COMPLETION OF ESTELLE® CYCLES REQUIRED IN PHASE III CONTRACEPTION STUDIES

* ESTELLE® PHASE III STUDIES REMAIN ON TRACK TO REPORT TOP-LINE RESULTS IN Q3 2018

* ‍TOP-LINE RESULTS CONTINUE TO BE EXPECTED IN Q3 2018 FOR EUROPE/RUSSIA STUDY AND IN Q1 2019 FOR US/CANADA TRIAL​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below